Bladder cancer trials in Italy
66 trials · From ClinicalTrials.gov and EU CTIS (euclinicaltrials.eu), checked 10 Nov 2026. Ask the study team whether a trial fits you.
Phase 1RecruitingTrial-stage medicine
A Phase 1/1b Study of IAM1363 in HER2 Cancers
- Where
- Florence, Milan, Naples
- Age
- 18 years and over
- People
- 383 worldwide
- Run by
- Iambic Therapeutics, Inc
See details and how to joinNCT06253871Registry updated 2026-09-09
Phase 3RecruitingResearch participation
Roll Over StudY for Patients Who Have Completed a Previous Oncology Study with Durvalumab
- Where
- Arezzo, Bari, Catania, Meldola, Milan, Modena, Padova, Pisa, Rome
- Age
- 18 years and over
- People
- 87 worldwide
- Run by
- Astrazeneca AB
See details and how to joinNCT05303532EU 2023-507337-22-00Registry updated 2026-09-08
Phase 2/3RecruitingTrial-stage medicine
Study of Datopotamab Deruxtecan Plus Carboplatin or Cisplatin Versus Gemcitabine Plus Carboplatin or Cisplatin in Participants With Locally Advanced or Metastatic Urothelial Carcinoma
- Where
- Naples, Roma, Rozzano
- Age
- 18 years and over
- People
- 630 worldwide
- Run by
- Daiichi Sankyo
See details and how to joinNCT07129993Registry updated 2026-08-20
Phase 1/2RecruitingTrial-stage medicine
A Study of Tulmimetostat DZR123 (CPI-0209) in Patients With Advanced Solid Tumors and Lymphomas
- Where
- Bologna, Milan, Rome, Rozzano
- Age
- 18 years and over
- People
- 300 worldwide
- Run by
- Novartis Pharmaceuticals
See details and how to joinNCT04104776EU 2023-508002-20-00Registry updated 2026-08-19
Phase 1/2RecruitingTrial-stage medicine
A Study of BMS-986340 as Monotherapy and as Combination Therapy in Participants With Advanced Solid Tumors
- Where
- Candiolo, Milan, Naples, Roma, Rozzano, Siena
- Age
- 18 years and over
- People
- 1,109 worldwide
- Run by
- Bristol-Myers Squibb
See details and how to joinNCT04895709Registry updated 2026-08-17
Phase 1/2RecruitingTrial-stage medicine
LEGEND Study: EG-70 in NMIBC Patients BCG-Unresponsive and High-Risk NMIBC Incompletely Treated With BCG or BCG-Naïve
- Where
- Acquaviva delle Fonti, Milan, Naples, Rome, Turin, Verona
- Age
- 18 years and over
- People
- 350 worldwide
- Run by
- enGene, Inc.
See details and how to joinNCT04752722EU 2024-512900-20-00Registry updated 2026-08-07
No phaseRecruitingResearch participation
Diagnostic Accuracy of 18F-FDG PET/CT in Muscle-invasive Bladder Cancer
- Where
- Ferrara
- Age
- 18 years and over
- People
- 60
- Run by
- University Hospital of Ferrara
See details and how to joinNCT07750470Registry updated 2026-08-06
No phaseRecruitingResearch participation
A Study to Evaluate Efficacy and Safety of Hydeal Cyst® Intravesical Instillations in Patients Treated With Intravesical Chemotherapy or Immunotherapy in Non-muscle Invasive Bladder Cancer
- Where
- Bergamo, Bologna, Foggia, Padova, Palermo, Udine, Verona
- Age
- 18 years and over
- People
- 200
- Run by
- Istituto Oncologico Veneto IRCCS
See details and how to joinNCT06245603Registry updated 2026-08-04
Phase 2RecruitingResearch participation
Cabozantinib plus Durvalumab in patients with advanced and chemotherapy-treated bladder carcinoma, of urothelial and non-urothelial histology: an open-label, single-centre, phase 2, single-arm proof-of-concept trial: ARCADIA study
- Where
- Milan
- Age
- 18 years and over
- People
- 122
- Run by
- Fondazione IRCCS Istituto Nazionale Dei Tumori
See details and how to join2023-509821-29-00EU 2023-509821-29-00Registry updated 2026-08-03
Phase 2/3RecruitingTrial-stage medicine
Phase 2/3 Trial of Izalontamab Brengitecan vs Platinum-based Chemotherapy for Metastatic Urothelial Cancer With Disease Progression on or After Immunotherapy
- Where
- Bari, Castelfranco Veneto, Genoa, Milan, Naples, Parma, Pisa, Rome
- Age
- 18 years and over
- People
- 470 worldwide
- Run by
- Bristol-Myers Squibb
See details and how to joinNCT07106762Registry updated 2026-07-29
Phase 2RecruitingTrial-stage medicine
A Study to Assess the Efficacy and Safety of FORE8394 in Participants With Cancer Harboring BRAF Alterations
- Where
- Meldola, Milan, Naples
- Age
- 8 years and over
- People
- 254 worldwide
- Run by
- Fore Biotherapeutics
See details and how to joinNCT05503797EU 2024-513578-23-00Registry updated 2026-07-27
Phase 2RecruitingResearch participation
Efficacy and safety of the combination of Cisplatin plus Nab-paclitaxel and Nivolumab with radiotherapy after maximal tumor resection in non-metastatic muscle invasive Bladder Cancer. (CA209-6E8, CNN-BC trial)
- Where
- Carpi, Florence, Genoa, Milan, Modena, Naples, Rome, Rozzano
- Age
- 18 years and over
- People
- 24
- Run by
- Fondazione Policlinico Universitario Agostino Gemelli IRCCS
See details and how to join2024-518937-26-00EU 2024-518937-26-00Registry updated 2026-07-23
Phase 2RecruitingTrial-stage medicine
A Study of Disitamab Vedotin Alone or With Pembrolizumab in Urothelial Cancer That Expresses HER2
- Where
- Aviano, Milan, Naples, Pisa, Rome, Terni
- Age
- 18 years and over
- People
- 372 worldwide
- Run by
- Seagen, a wholly owned subsidiary of Pfizer
See details and how to joinNCT04879329EU 2022-500030-28-01Registry updated 2026-07-22
Phase 3RecruitingTrial-stage medicine
An Open-label Study to Investigate the Efficacy and Safety of Dato-DXd + Rilvegostomig vs SoC in Adult Participants With High-risk MIUC
- Where
- Bari, Florence, Padova, Roma, Rozzano, Tricase
- Age
- 18 years and over
- People
- 915 worldwide
- Run by
- AstraZeneca
See details and how to joinNCT07720284Registry updated 2026-07-22
Phase 1/2RecruitingTrial-stage medicine
A Study to Investigate ALE.P03 as Monotherapy in Adult Patients With Selected Advanced or Metastatic CLDN1+ Solid Tumors
- Where
- Milan, Ravenna, Rossano, Siena
- Age
- 18 years and over
- People
- 180 worldwide
- Run by
- Alentis Therapeutics AG
See details and how to joinNCT07169734EU 2025-521441-24-00Registry updated 2026-07-02
Phase 2Not yet recruitingResearch participation
Maintenance AVElumab after SECond line platinum-based chemotherapy for metastatic urothelial carcinoma: AVESEC trial – GOIRC-02-2025
- Where
- Bari, Bologna, Florence, Foggia, Genoa, Macerata, Meldola, Milan, Modena, Naples, Padova, Palermo, Parma, Perugia, Reggio Emilia, Rome, Terni, Verona
- Age
- 18 years to 64 years
- People
- 144
- Run by
- G.O.I.R.C. Gruppo Oncologico Italiano Di Ricerca Clinica
See details and how to join2025-524077-16-00EU 2025-524077-16-00Registry updated 2026-05-12
No phaseNot yet recruitingResearch participation
Hyperthermic Intravesical Chemotherapy (HIVEC) in BCG-Non-Responsive High-Grade NMIBC Patients
- Where
- Pozzuoli
- Age
- 18 years and over
- People
- 50
- Run by
- AC.TA. S.r.l.
See details and how to joinNCT07231809Registry updated 2026-05-06
No phaseRecruitingResearch participation
Randomized Trial of stAndard of Care With or Without Metastases-directed Stereotactic Body Radiation Therapy in Patients Affected by Oligometastatic uRothelial carcinomA
- Where
- Rozzano
- Age
- 18 years and over
- People
- 44
- Run by
- Istituto Clinico Humanitas
See details and how to joinNCT07413523Registry updated 2026-04-30
No phaseRecruitingResearch participation
Study on the Effects of Drugs That Modulate the Endocannabinoid System on Spontaneous and Induced Contractility of the Human Detrusor Muscle
- Where
- Rome
- Age
- 18 years and over
- People
- 65
- Run by
- Fondazione Policlinico Universitario Agostino Gemelli IRCCS
See details and how to joinNCT07545694Registry updated 2026-04-22
Phase 2Not yet recruitingTrial-stage medicine
Maintenance AVElumab After SECond Line Platinum-based Chemotherapy for Metastatic Urothelial Carcinoma
- Where
- Bari, Bologna, Florence, Foggia, Genova, Meldola, Milan, Modena, Naples, Padova, Palermo, Parma, Province of Macerata, Reggio Emilia, Roma, Terni, Verona
- Age
- 18 years and over
- People
- 144
- Run by
- Gruppo Oncologico Italiano di Ricerca Clinica
See details and how to joinNCT07460245Registry updated 2026-03-10
No phaseRecruitingResearch participation
The MOMENTUM Study: The Multiple Outcome Evaluation of Radiation Therapy Using the MR-Linac Study
- Where
- Brescia, Negrar
- Age
- 18 years and over
- People
- 8,000 worldwide
- Run by
- UMC Utrecht
See details and how to joinNCT04075305Registry updated 2026-03-05
No phaseRecruitingTrial-stage medicine
INTEGRATIVE "MULTI-OMICS" AND FUNCTIONAL PLATFORM FOR THE COMPLETE DIAGNOSTIC CHARACTERIZATION OF TUMORS: THE ITALIAN TUMOR CHEMOGENOMIC PROFILER (IT-TCP)
- Where
- Palermo, Perugia
- Age
- 1 year and over
- People
- 300
- Run by
- Azienda Ospedaliero-Universitaria di Parma
See details and how to joinNCT07403630Registry updated 2026-02-17
Phase 4RecruitingTrial-stage medicine
Vesical Imaging-Reporting and Data System (VI-RADS) Followed by Photodynamic Trans-urethral Resection of Bladder Tumours (PDD-TURBT) to Avoid Secondary Resections (Re-TURBT) in Non-Muscle Invasive Bladder Cancers (NMIBCs)
- Where
- Rome
- Age
- 18 years and over
- People
- 327
- Run by
- University of Roma La Sapienza
See details and how to joinNCT05962541Registry updated 2025-12-31
Phase 2RecruitingTrial-stage medicine
Erdafitinib Monotherapy or in Combination With Cetrelimab in Muscle-invasive Bladder Cancer Patients With Fibroblast Growth Factor Receptor (FGFR ) Gene Alterations
- Where
- Milan, Turin
- Age
- 18 years and over
- People
- 90 worldwide
- Run by
- Spanish Oncology Genito-Urinary Group
See details and how to joinNCT06511648EU 2024-512573-27-01Registry updated 2025-12-19
Phase 3RecruitingTrial-stage medicine
Treatment Expedition With MRI Processing and Optimization for Muscle Invasive Bladder Cancer
- Where
- Rome
- Age
- 18 years and over
- People
- 92
- Run by
- University of Rome Tor Vergata
See details and how to joinNCT07067749Registry updated 2025-07-24
All Bladder cancer trials and the map
This page is not medical advice. Talk to your doctor before contacting a trial.